Disease #05793 (IMD74 (immunodeficiency, type 74, COVID19-related, X-linked), OMIM:301051)

Official abbreviation	IMD74
Name	immunodeficiency, type 74, COVID19-related, X-linked
OMIM ID	301051
Human Phenotype Ontology Project (HPO)	HPO
Inheritance	X-linked recessive
Individuals reported having this disease	233
Phenotype entries for this disease	233
Associated with 1 gene	TLR7
Associated tissues	-
Disease features	-
Remarks	-
Date created	2020-07-24 22:16:50 +02:00 (CEST)
Date last edited	2025-08-26 15:50:59 +02:00 (CEST)

Individuals

Legend

Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.

ID_report: ID of the individual that can be publically shared, e.g. as listed in a publication

Reference: reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, incl. link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"

Remarks: remarks about the individual

Gender: gender individual
All options:

? = unknown
- = not applicable
F = female
M = male
rF = raised as female
rM = raised as male

Consanguinity: indicates whether the parents are related (consanguineous), not related (non-consanguineous) or whether consanguinity is not known (unknown)
All options:

no = non-consanguineous parents
yes = consanguineous parents
likely = consanguinity likely
? = unknown
- = not applicable

Country: where (country) does the individual live/recently came from. Give additional details (population, specific sub-group) and when parents come from different countries in "Population". Belgium = individual lives in/recently came from Belgium, (France) = reported by laboratory in France, individual's country of origin not sure
All options:

? (unknown)
- (not applicable)
Afghanistan
(Afghanistan)
Albania
(Albania)
Algeria
(Algeria)
American Samoa
(American Samoa)
Andorra
(Andorra)
Angola
(Angola)
Anguilla
(Anguilla)
Antarctica
(Antarctica)
Antigua and Barbuda
(Antigua and Barbuda)
Argentina
(Argentina)
Armenia
(Armenia)
Aruba
(Aruba)
Australia
(Australia)
Austria
(Austria)
Azerbaijan
(Azerbaijan)
Bahamas
(Bahamas)
Bahrain
(Bahrain)
Bangladesh
(Bangladesh)
Barbados
(Barbados)
Belarus
(Belarus)
Belgium
(Belgium)
Belize
(Belize)
Benin
(Benin)
Bermuda
(Bermuda)
Bhutan
(Bhutan)
Bolivia
(Bolivia)
Bosnia and Herzegovina
(Bosnia and Herzegovina)
Botswana
(Botswana)
Bouvet Island
(Bouvet Island)
Brazil
(Brazil)
British Indian Ocean Territory
(British Indian Ocean Territory)
Brunei Darussalam
(Brunei Darussalam)
Bulgaria
(Bulgaria)
Burkina Faso
(Burkina Faso)
Burundi
(Burundi)
Cambodia
(Cambodia)
Cameroon
(Cameroon)
Canada
(Canada)
Cape Verde
(Cape Verde)
Cayman Islands
(Cayman Islands)
Central African Republic
(Central African Republic)
Central Europe
Chad
(Chad)
Chile
(Chile)
China
(China)
Christmas Island
(Christmas Island)
Cocos (Keeling Islands)
(Cocos (Keeling Islands))
Colombia
(Colombia)
Comoros
(Comoros)
Congo
(Congo)
Cook Islands
(Cook Islands)
Costa Rica
(Costa Rica)
Cote D'Ivoire (Ivory Coast)
(Cote D'Ivoire (Ivory Coast))
Croatia (Hrvatska)
(Croatia (Hrvatska))
Cuba
(Cuba)
Cyprus
(Cyprus)
Czech Republic
(Czech Republic)
Denmark
(Denmark)
Djibouti
(Djibouti)
Dominica
(Dominica)
Dominican Republic
(Dominican Republic)
East Timor
(East Timor)
Ecuador
(Ecuador)
Egypt
(Egypt)
El Salvador
(El Salvador)
England
(England)
Equatorial Guinea
(Equatorial Guinea)
Eritrea
(Eritrea)
Estonia
(Estonia)
Ethiopia
(Ethiopia)
Falkland Islands (Malvinas)
(Falkland Islands (Malvinas))
Faroe Islands
(Faroe Islands)
Fiji
(Fiji)
Finland
(Finland)
France
(France)
Gabon
(Gabon)
Gambia
(Gambia)
Georgia
(Georgia)
Germany
(Germany)
Ghana
(Ghana)
Gibraltar
(Gibraltar)
Greece
(Greece)
Greenland
(Greenland)
Grenada
(Grenada)
Guadeloupe
(Guadeloupe)
Guam
(Guam)
Guatemala
(Guatemala)
Guiana, French
(Guiana, French)
Guinea
(Guinea)
Guinea-Bissau
(Guinea-Bissau)
Guyana
(Guyana)
Haiti
(Haiti)
Heard and McDonald Islands
(Heard and McDonald Islands)
Honduras
(Honduras)
Hong Kong
(Hong Kong)
Hungary
(Hungary)
Iceland
(Iceland)
India
(India)
Indonesia
(Indonesia)
Iran
(Iran)
Iraq
(Iraq)
Ireland
(Ireland)
Israel
(Israel)
Italy
(Italy)
Jamaica
(Jamaica)
Japan
(Japan)
Jordan
(Jordan)
Kazakhstan
(Kazakhstan)
Kenya
(Kenya)
Kiribati
(Kiribati)
Korea
(Korea)
Korea, North (People's Republic)
(Korea, North (People's Republic))
Korea, South (Republic)
(Korea, South (Republic))
Kosovo
(Kosovo)
Kuwait
(Kuwait)
Kyrgyzstan (Kyrgyz Republic)
(Kyrgyzstan (Kyrgyz Republic))
Laos
(Laos)
Latvia
(Latvia)
Lebanon
(Lebanon)
Lesotho
(Lesotho)
Liberia
(Liberia)
Libya
(Libya)
Liechtenstein
(Liechtenstein)
Lithuania
(Lithuania)
Luxembourg
(Luxembourg)
Macau
(Macau)
Macedonia
(Macedonia)
Madagascar
(Madagascar)
Malawi
(Malawi)
Malaysia
(Malaysia)
Maldives
(Maldives)
Mali
(Mali)
Mallorca
(Mallorca)
Malta
(Malta)
Marshall Islands
(Marshall Islands)
Martinique
(Martinique)
Mauritania
(Mauritania)
Mauritius
(Mauritius)
Mayotte
(Mayotte)
Mexico
(Mexico)
Micronesia
(Micronesia)
Moldova
(Moldova)
Monaco
(Monaco)
Mongolia
(Mongolia)
Montserrat
(Montserrat)
Morocco
(Morocco)
Mozambique
(Mozambique)
Myanmar
(Myanmar)
Namibia
(Namibia)
Nauru
(Nauru)
Nepal
(Nepal)
Netherlands
(Netherlands)
Netherlands Antilles
(Netherlands Antilles)
Neutral Zone (Saudia Arabia/Iraq)
(Neutral Zone (Saudia Arabia/Iraq))
New Caledonia
(New Caledonia)
New Zealand
(New Zealand)
Nicaragua
(Nicaragua)
Niger
(Niger)
Nigeria
(Nigeria)
Niue
(Niue)
Norfolk Island
(Norfolk Island)
Northern Ireland
(Northern Ireland)
Northern Mariana Islands
(Northern Mariana Islands)
Norway
(Norway)
Oman
(Oman)
Pakistan
(Pakistan)
Palau
(Palau)
Palestine
(Palestine)
Panama
(Panama)
Papua New Guinea
(Papua New Guinea)
Paraguay
(Paraguay)
Peru
(Peru)
Philippines
(Philippines)
Pitcairn
(Pitcairn)
Poland
(Poland)
Polynesia, French
(Polynesia, French)
Portugal
(Portugal)
Puerto Rico
(Puerto Rico)
Qatar
(Qatar)
Reunion
(Reunion)
Romania
(Romania)
Russia
(Russia)
Russian Federation
(Russian Federation)
Rwanda
(Rwanda)
S. Georgia and S. Sandwich Isls.
(S. Georgia and S. Sandwich Isls.)
Saint Kitts and Nevis
(Saint Kitts and Nevis)
Saint Lucia
(Saint Lucia)
Saint Vincent and The Grenadines
(Saint Vincent and The Grenadines)
Samoa
(Samoa)
San Marino
(San Marino)
Sao Tome and Principe
(Sao Tome and Principe)
Saudi Arabia
(Saudi Arabia)
Scotland
(Scotland)
Senegal
(Senegal)
Serbia
(Serbia)
Seychelles
(Seychelles)
Sierra Leone
(Sierra Leone)
Singapore
(Singapore)
Slovakia (Slovak Republic)
(Slovakia (Slovak Republic))
Slovenia
(Slovenia)
Solomon Islands
(Solomon Islands)
Somalia
(Somalia)
South Africa
(South Africa)
Southern Territories, French
(Southern Territories, French)
Soviet Union (former)
(Soviet Union (former))
Spain
(Spain)
Sri Lanka
(Sri Lanka)
St. Helena, Ascension and Tristan da
Cunha
(St. Helena, Ascension and Tristan da
Cunha)
St. Pierre and Miquelon
(St. Pierre and Miquelon)
Sudan
(Sudan)
Sudan, South
(Sudan, South)
Suriname
(Suriname)
Svalbard and Jan Mayen Islands
(Svalbard and Jan Mayen Islands)
Swaziland
(Swaziland)
Sweden
(Sweden)
Switzerland
(Switzerland)
Syria
(Syria)
Taiwan
(Taiwan)
Tajikistan
(Tajikistan)
Tanzania
(Tanzania)
Thailand
(Thailand)
Togo
(Togo)
Tokelau
(Tokelau)
Tonga
(Tonga)
Trinidad and Tobago
(Trinidad and Tobago)
Tunisia
(Tunisia)
Turkey
(Turkey)
Turkmenistan
(Turkmenistan)
Turks and Caicos Islands
(Turks and Caicos Islands)
Tuvalu
(Tuvalu)
Uganda
(Uganda)
Ukraine
(Ukraine)
United Arab Emirates
(United Arab Emirates)
United Kingdom (Great Britain)
(United Kingdom (Great Britain))
United States
(United States)
Uruguay
(Uruguay)
US Minor Outlying Islands
(US Minor Outlying Islands)
Uzbekistan
(Uzbekistan)
Vanuatu
(Vanuatu)
Vatican City State (Holy See)
(Vatican City State (Holy See))
Venezuela
(Venezuela)
Viet Nam
(Viet Nam)
Virgin Islands (British)
(Virgin Islands (British))
Virgin Islands (US)
(Virgin Islands (US))
Wales
(Wales)
Wallis and Futuna Islands
(Wallis and Futuna Islands)
Western Sahara
(Western Sahara)
Yemen
(Yemen)
Yugoslavia
(Yugoslavia)
Zaire
(Zaire)
Zambia
(Zambia)
Zimbabwe
(Zimbabwe)

Population: population the individual (or ancestors) belongs to; e.g. white, gypsy, Jewish-Ashkenazi, Africa-N, Sardinia, etc.

Age at death: age at which the individual deceased (when applicable):

35y = 35 years
>43y = still alive at 43y
04y08m = 4 years and 8 months
00y00m01d12h = 1 day and 12 hours
18y? = around 18 years
30y-40y = between 30 and 40 years
>54y = older than 54
? = unknown

VIP: individual/phenotype VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.

Data_av: are additional data available upon request: e.g. pedigree (yes/no/?)

Treatment: treatment of patient

Variants in genes: The individual has variants for this gene.

Panel size: Number of individuals this entry represents; e.g. 1 for an individual, 5 for a family with 5 affected members.

How to query this table

All list views have search fields which can be used to search data. You can search for a complete word or you can search for a part of a search term. If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify. Note that search terms are case-insensitive and that wildcards such as * are treated as normal text! For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.

Operator	Column type	Example	Matches
	Text	Arg	all entries containing 'Arg'
space	Text	Arg Ser	all entries containing 'Arg' and 'Ser'
\|	Text	Arg\|Ser	all entries containing 'Arg' or 'Ser'
!	Text	!fs	all entries not containing 'fs'
^	Text	^p.(Arg	all entries beginning with 'p.(Arg'
$	Text	Ser)$	all entries ending with 'Ser)'
=""	Text	=""	all entries with this field empty
=""	Text	="p.0"	all entries exactly matching 'p.0'
!=""	Text	!=""	all entries with this field not empty
!=""	Text	!="p.0"	all entries not exactly matching 'p.0?'
combination	Text	*\|Ter !fs	all entries containing '*' or 'Ter' but not containing 'fs'
	Date	2020	all entries matching the year 2020
\|	Date	2020-03\|2020-04	all entries matching March or April, 2020
!	Date	!2020-03	all entries not matching March, 2020
<	Date	<2020	all entries before the year 2020
<=	Date	<=2020-06	all entries in or before June, 2020
>	Date	>2020-06	all entries after June, 2020
>=	Date	>=2020-06-15	all entries on or after June 15th, 2020
combination	Date	2019\|2020 <2020-03	all entries in 2019 or 2020, and before March, 2020
	Numeric	23	all entries exactly matching 23
\|	Numeric	23\|24	all entries exactly matching 23 or 24
!	Numeric	!23	all entries not exactly matching 23
<	Numeric	<23	all entries lower than 23
<=	Numeric	<=23	all entries lower than, or equal to, 23
>	Numeric	>23	all entries higher than 23
>=	Numeric	>=23	all entries higher than, or equal to, 23
combination	Numeric	>=20 <30 !23	all entries with values from 20 to 29, but not equal to 23

Some more advanced examples:

Example	Matches
Asian	all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc.
Asian !Caucasian	all entries containing 'Asian' but not containing 'Caucasian'
Asian\|African !Caucasian	all entries containing 'Asian' or 'African', but not containing 'Caucasian'
"South Asian"	all entries containing 'South Asian', but not containing 'South East Asian'

To sort on a certain column, click on the column header or on the arrows. If that column is already selected to sort on, the sort order will be swapped. The column currently sorted on has a darker blue background color than the other columns. The up and down arrows next to the column name indicate the current sorting direction. When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.

233 entries on 3 pages. Showing entries 1 - 100.

	Legend	How to query	« First	‹ Prev		1	2	3		Next ›	Last »

Individual ID	ID_report	Reference	Remarks	Gender	Consanguinity	Country	Population	Age at death	VIP	Data_av	Treatment	Disease	Phenotype details	Genes screened	Variants in genes	Variants	Panel size	Owner
00334283	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, IFNAR2	3	1	Liu Wenbing
00334284	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, FADD, POLE	3	1	Liu Wenbing
00334285	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	ATM, CASP8, TP53BP1, TYK2	4	1	Liu Wenbing
00334286	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	BLM, IGLL1, RNF31, TIRAP	4	1	Liu Wenbing
00334287	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, FAT4, SPINK5, TLR4	6	1	Liu Wenbing
00334288	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, IL12B, KMT2D, RNF31, TRAF2	6	1	Liu Wenbing
00334289	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	FAT4, MYD88, TCF3, TYK2	4	1	Liu Wenbing
00334290	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	DOCK2, IFIH1, IL17RA, TCN2	4	1	Liu Wenbing
00334291	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	DCLRE1B, MAVS, TLR2, TLR5	4	1	Liu Wenbing
00334292	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CTPS1, FASLG, TTC37	3	1	Liu Wenbing
00334293	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	LYST, PLCG2, TCN2, TIRAP	4	1	Liu Wenbing
00334294	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	TTC7A	1	1	Liu Wenbing
00334295	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	BLM, MDC1, TBX1, TCF3, TLR10	5	1	Liu Wenbing
00334296	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IL12B, POLE, TTC37	3	1	Liu Wenbing
00334297	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CHD7, FUT2, IL2RG, SPINK5, TCN2, TLR10	6	1	Liu Wenbing
00334298	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	DDX58, FASLG, HLA-C, RFC1	4	1	Liu Wenbing
00334299	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IL17RA, IL7R, TBX1, TLR9, TYK2	5	1	Liu Wenbing
00334300	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	DDX3X	1	1	Liu Wenbing
00334301	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	TTC37, UNC13D	2	1	Liu Wenbing
00334302	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CHD7, EPG5, IL12B, RAD54L, TTC37	5	1	Liu Wenbing
00334303	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IFIH1, IL17RA, TCN2, TNFAIP3, TRAF2	5	1	Liu Wenbing
00334304	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, FAT4, FUT2, IL12B, LAT, PLCG2, TYK2	8	1	Liu Wenbing
00334305	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	BLM, JAK3, TCN2, TLR4	4	1	Liu Wenbing
00334306	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	TLR6, TTC7A	2	1	Liu Wenbing
00334307	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IKBKE, MSH6, RFC1, TYK2	4	1	Liu Wenbing
00334308	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	BCL10, CHD7, FUT2	3	1	Liu Wenbing
00334309	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	MSH6, TTC7A	2	1	Liu Wenbing
00334310	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	POLE, TLR2, UNC13D	3	1	Liu Wenbing
00334311	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	EPG5, JAK3, SPINK5	3	1	Liu Wenbing
00334312	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	TCF3	1	1	Liu Wenbing
00334313	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IL12B, JAK3, KMT2D, TYK2	5	1	Liu Wenbing
00334314	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CHD7, RNF31, TFRC	3	1	Liu Wenbing
00334315	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IFNAR2, TNFRSF13C, TRAF2	3	1	Liu Wenbing
00334316	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	EPG5, RPA1, SPINK5	3	1	Liu Wenbing
00334317	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	LRBA, LYST, MAVS	4	1	Liu Wenbing
00334318	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CCR5, TTC37, TTC7A	3	1	Liu Wenbing
00334319	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CCR5, IFIH1, LIG3, TCN2, ZBTB24	5	1	Liu Wenbing
00334320	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	MSH6, NHP2, TLR1	3	1	Liu Wenbing
00334321	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	EPG5, GINS1	2	1	Liu Wenbing
00334322	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	FASLG, IL10RA, IL12B, TBX1	4	1	Liu Wenbing
00334323	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CR2, TTC37	2	1	Liu Wenbing
00334324	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	KMT2D, MSH6, RFC1, SEMA3E, TCN2, TLR6, TYK2	7	1	Liu Wenbing
00334325	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CHD7, FAT4, GINS1, TBK1, TLR5, TRAF1, TTC37	7	1	Liu Wenbing
00334326	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	MSH6, TYK2, UNC13D	3	1	Liu Wenbing
00334327	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	BLM, DHX58, IL17RA, LIG1, TCF3	5	1	Liu Wenbing
00334343	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, IRAK1, KMT2D, LIG1, PTPRC, TCN2, TP53BP1	9	1	Liu Wenbing
00334344	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	TCN2, TTC37	2	1	Liu Wenbing
00334345	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, MSH6, TBX1	4	1	Liu Wenbing
00334346	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, IFNAR2	3	1	Liu Wenbing
00334347	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	BLM, POLE2, RELB, TCN2	4	1	Liu Wenbing
00334348	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	LRBA, LYST, POLE, UNC13D	4	1	Liu Wenbing
00334349	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IFIH1, RASGRP1, TCN2, TIRAP, TLR5	5	1	Liu Wenbing
00334350	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IFIH1, TLR6	2	1	Liu Wenbing
00334351	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, FAT4, TIRAP	4	1	Liu Wenbing
00334352	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	EPG5, MYSM1, TLR4, TLR5, TTC37	5	1	Liu Wenbing
00334353	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	POLE2, TCN2	2	1	Liu Wenbing
00334354	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	BLM, LIG3, POLE, TCN2	5	1	Liu Wenbing
00334355	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	ATM, IFNAR2	2	1	Liu Wenbing
00334356	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CR2, LRBA, PLCG2, TYK2	4	1	Liu Wenbing
00334357	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	-	-	1	Liu Wenbing
00334358	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IFNAR2	1	1	Liu Wenbing
00334359	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	MSH6, TLR1, TYK2	3	1	Liu Wenbing
00334360	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CCR5, CHD7	2	1	Liu Wenbing
00334361	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	DOCK8, IL12RB1, RASGRP1, STXBP2, TCN2, TYK2	6	1	Liu Wenbing
00334362	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	DOCK2, IRF2BP2, LYST, MYSM1	4	1	Liu Wenbing
00334363	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	MYSM1, RAG2, TYK2	3	1	Liu Wenbing
00334364	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IFIH1	1	1	Liu Wenbing
00334365	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	LIG3, NLRC4, TLR4, TNFRSF13B	4	1	Liu Wenbing
00334366	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	LRBA, LYST, TBX1, TNFRSF13B	4	1	Liu Wenbing
00334367	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CCR5, MAVS, PTPRC, TCN2, TFRC, TLR4, WIPF1	7	1	Liu Wenbing
00334368	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	EPG5, IL17RC, MAVS, MSH6, NHP2, POLE, RFC1	7	1	Liu Wenbing
00334369	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	RAG2, TYK2	3	1	Liu Wenbing
00334370	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IL17RA, TBX1, TLR4, TRAF2	4	1	Liu Wenbing
00334371	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, FAT4, LIG1, LIG4, MAVS, MSH6, PTPRC, RAB27A, TBX1, TYK2	12	1	Liu Wenbing
00334373	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	EPG5, IFNAR2	2	1	Liu Wenbing
00334374	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IL17RA, NLRC4, POLE, SEMA3E	4	1	Liu Wenbing
00334375	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CHD7, DCLRE1C, MSH6	3	1	Liu Wenbing
00334376	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	LAT, NFKB1, RNF31, TYK2	4	1	Liu Wenbing
00334378	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	DCLRE1C, FAT4, PLCG2	3	1	Liu Wenbing
00334380	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	-	-	1	Liu Wenbing
00334381	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	ATM, CCR5, DHX58, FUT2, IL12B, POLE2, TCN2, TLR4, TTC37	9	1	Liu Wenbing
00334387	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	LIG3, NLRC4, TLR4, TNFRSF13B	4	1	Liu Wenbing
00334390	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	LIG3	1	1	Liu Wenbing
00334393	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CCBE1, TLR4	2	1	Liu Wenbing
00334394	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C2, MAVS	2	1	Liu Wenbing
00334395	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C3, KMT2D, TYK2	3	1	Liu Wenbing
00334396	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IFNAR2, LRBA, TBX1, TYK2	4	1	Liu Wenbing
00334397	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	MSH6	1	1	Liu Wenbing
00334398	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	TLR1	1	1	Liu Wenbing
00334399	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	TFRC, TRAF1	2	1	Liu Wenbing
00334400	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, IRF7, TCN2, TLR4	5	1	Liu Wenbing
00334401	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IRF9, TCN2	2	1	Liu Wenbing
00334402	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	C6, CD70, DOCK2, TLR4	4	1	Liu Wenbing
00334403	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CHD7, FUT2, IFNAR2, TCN2, TFRC	5	1	Liu Wenbing
00334404	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	IFIH1, STAT2, TP53BP1	3	1	Liu Wenbing
00334405	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CCBE1, CHD7, IFNAR2, NFKB1, SEMA3E, TRAF2, UNC13D	7	1	Liu Wenbing
00334406	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CCR5, CHD7, EPG5, LRBA, TIRAP, TTC37	6	1	Liu Wenbing
00334477	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	AP3B1, LIG3, POLE, STXBP2, TCN2	5	1	Liu Wenbing
00334478	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	FAT4, IFIH1, TCN2, TTC37	4	1	Liu Wenbing
00334479	-	PubMed: Luo 2021, Journal: Luo 2021	analysis 233 patients	-	-	China	-	-	-	-	-	IMD74	hospitalized after COVID-19 infection,	-	CCR5, CHD7, EPG5, TIRAP	4	1	Liu Wenbing

	Legend	How to query	« First	‹ Prev		1	2	3		Next ›	Last »

Global Variome shared LOVD